SCHEMBL2990049

SCHEMBL2990049

COc1ccc(NS(=O)(=O)c2ccc(-c3ccc(C)o3)c(F)c2)cc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.47
MAPT P10636 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 3/20 0.47
PKM P14618 2/20 0.47
THRB P10828 1/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GHSR Q92847 7/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KIT P10721 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664000 0.84 LMNA (0.45) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL2985998 0.84 GHSR (0.51) LMNAALDH1A1THRBTSHRGHSR
SCHEMBL2979801 0.84 ALDH1A1 (0.50) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL2992760 0.83 GHSR (0.51) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL4664203 0.82 GHSR (0.44) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL2984221 0.81 HTR6 (0.52) ALDH1A1PKMGHSRKITCA1
SCHEMBL2992279 0.79 GHSR (0.43) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL13245956 0.79 ALDH1A1 (0.50) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL4664054 0.79 KDM4E (0.45) LMNAMAPTMEN1KMT2AALDH1A1
SCHEMBL13245951 0.78 ALDH1A1 (0.46) LMNAMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed
EP-2007716-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 EP disclosed
WO-2007118852-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR LMNA 4700/4885MAPT 4610/4885MEN1 1128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.